E. van Garderen

3.1k total citations
46 papers, 2.3k citations indexed

About

E. van Garderen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. van Garderen has authored 46 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. van Garderen's work include Growth Hormone and Insulin-like Growth Factors (14 papers), Veterinary Oncology Research (13 papers) and TGF-β signaling in diseases (6 papers). E. van Garderen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (14 papers), Veterinary Oncology Research (13 papers) and TGF-β signaling in diseases (6 papers). E. van Garderen collaborates with scholars based in Netherlands, Belgium and United Kingdom. E. van Garderen's co-authors include Gerard R. Rutteman, Jan A. Mol, Theo van Laar, Ralph Meuwissen, John Zevenhoven, Sirith Douma, Daniel S. Peeper, Marjolein van Egmond, Jack A. Schalken and Annemiek B. van Spriel and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

E. van Garderen

45 papers receiving 2.2k citations

Peers

E. van Garderen
H. Gerber Switzerland
Gerard R. Rutteman Netherlands
Y Ohtsuki Japan
Oliver A. Garden United Kingdom
Krista M. D. La Perle United States
Donald Bellgrau United States
Clinton D. Lothrop United States
H. Gerber Switzerland
E. van Garderen
Citations per year, relative to E. van Garderen E. van Garderen (= 1×) peers H. Gerber

Countries citing papers authored by E. van Garderen

Since Specialization
Citations

This map shows the geographic impact of E. van Garderen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. van Garderen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. van Garderen more than expected).

Fields of papers citing papers by E. van Garderen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. van Garderen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. van Garderen. The network helps show where E. van Garderen may publish in the future.

Co-authorship network of co-authors of E. van Garderen

This figure shows the co-authorship network connecting the top 25 collaborators of E. van Garderen. A scholar is included among the top collaborators of E. van Garderen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. van Garderen. E. van Garderen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garderen, E. van, et al.. (2022). Distinct Mannheimia haemolytica serotypes isolated from fatal infections in veal calves and dairy cows. The Veterinary Journal. 292. 105940–105940. 7 indexed citations
2.
Schaik, G. van, et al.. (2020). Emergence of fatal Mannheimia haemolytica infections in cattle in the Netherlands. The Veterinary Journal. 268. 105576–105576. 11 indexed citations
3.
Vernooij, J.C.M., E. van Garderen, Hille Fieten, et al.. (2019). Quantification of the health-status of the Dutch Labrador retriever population. Preventive Veterinary Medicine. 171. 104764–104764. 1 indexed citations
4.
Garderen, E. van, et al.. (2015). Calvarium hyperostosis syndroom bij een jonge weimaraner. Vlaams Diergeneeskundig Tijdschrift. 84(3). 1 indexed citations
5.
Oosterling, Steven J., Gerben J. van der Bij, Gerrit A. Meijer, et al.. (2005). Macrophages direct tumour histology and clinical outcome in a colon cancer model. The Journal of Pathology. 207(2). 147–155. 101 indexed citations
6.
Saeland, Eiríkur, Gestur Vidarsson, Jeanette H.W. Leusen, et al.. (2003). Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice. The Journal of Immunology. 170(12). 6158–6164. 65 indexed citations
7.
Garderen, E. van & Jack A. Schalken. (2002). Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Molecular and Cellular Endocrinology. 197(1-2). 153–165. 31 indexed citations
8.
Cangül, İ. Taci, Merel van Wijnen, E. van Garderen, & T. S. G. A. M. van den Ingh. (2002). Clinico‐pathological Aspects of Canine Cutaneous and Mucocutaneous Plasmacytomas. Journal of Veterinary Medicine Series A. 49(6). 307–312. 49 indexed citations
9.
Teske, Erik, et al.. (2002). Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Molecular and Cellular Endocrinology. 197(1-2). 251–255. 137 indexed citations
10.
Mol, Jan A., et al.. (2002). Progestin-induced Mammary Growth Hormone (GH) Production. Advances in experimental medicine and biology. 480. 71–76. 14 indexed citations
11.
Ingh, T. S. G. A. M. van den, et al.. (2001). Immune response in hormonally-induced prostatic hyperplasia in the dog. Veterinary Immunology and Immunopathology. 78(3-4). 297–303. 18 indexed citations
12.
Leeuwen, Irma S Lantinga‐van, E. van Garderen, Gerard R. Rutteman, & Jan A. Mol. (2000). Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. The Journal of Steroid Biochemistry and Molecular Biology. 75(4-5). 219–228. 32 indexed citations
13.
Garderen, E. van, et al.. (2000). Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog. The Prostate. 44(1). 40–48. 27 indexed citations
14.
Cangül, İ. Taci, et al.. (1999). Tyrosinase gene expression in clear cell sarcoma indicates a melanocyte origin: insight from the first reported canine case. Apmis. 107(7-12). 982–988. 15 indexed citations
15.
Garderen, E. van, Joost F. Swennenhuis, Gerard R. Rutteman, et al.. (1999). Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors. Endocrinology. 140(12). 5907–5914. 28 indexed citations
16.
Wijnberg, Inge D., et al.. (1998). Atrial fibrillation associated with central nervous symptoms and colic in a horse: A case of equine cardiomyopathy. Veterinary Quarterly. 20(2). 73–76. 1 indexed citations
17.
Chu, Lee Lee, et al.. (1998). Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Research and Treatment. 50(1). 11–25. 46 indexed citations
18.
Selman, P.J., E. van Garderen, Jan A. Mol, & T.S.G.A.M. van den Ingh. (1995). Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone. Veterinary Quarterly. 17(4). 128–133. 14 indexed citations
19.
Mol, Jan A., et al.. (1995). Growth hormone mRNA in mammary gland tumors of dogs and cats.. Journal of Clinical Investigation. 95(5). 2028–2034. 102 indexed citations
20.
Garderen, E. van, Kerstin Müller, G.H. Wentink, & T.S.G.A.M. van den Ingh. (1994). Post‐mortem findings in calves suffering from bovine leukocyte adhesion deficiency [BLAD). Veterinary Quarterly. 16(1). 24–26. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026